End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.24 EGP | -2.18% | -8.94% | -28.66% |
03-03 | Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-05 | Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index | CI |
Sales 2024 * | 36.64B 782M 62.07B | Sales 2025 * | 46.76B 998M 79.2B | Capitalization | 2.26B 48.22M 3.82B |
---|---|---|---|---|---|
Net income 2024 * | 417M 8.9M 706M | Net income 2025 * | 448M 9.57M 759M | EV / Sales 2024 * | 0.16 x |
Net Debt 2024 * | 3.65B 77.91M 6.18B | Net Debt 2025 * | 3.44B 73.49M 5.83B | EV / Sales 2025 * | 0.12 x |
P/E ratio 2024 * |
7.47
x | P/E ratio 2025 * |
5.42
x | Employees | 5,500 |
Yield 2024 * |
2.61% | Yield 2025 * |
2.95% | Free-Float | 61.4% |
1 day | -2.18% | ||
1 week | -8.94% | ||
Current month | -5.49% | ||
1 month | -15.15% | ||
3 months | -41.36% | ||
6 months | -8.20% | ||
Current year | -28.66% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 17/12/00 | |
Chief Executive Officer | - | 17/12/00 | |
Momen Gomaa
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | - | |
Chief Executive Officer | - | 17/12/00 | |
Chief Executive Officer | - | 17/12/00 |
Date | Price | Change | Volume |
---|---|---|---|
14/05/24 | 2.24 | -2.18% | 9,806,960 |
13/05/24 | 2.29 | +2.69% | 11,027,130 |
12/05/24 | 2.23 | -7.85% | 16,522,550 |
09/05/24 | 2.42 | -0.82% | 4,970,738 |
08/05/24 | 2.44 | -0.81% | 11,752,150 |
End-of-day quote Egyptian Exchange, May 13, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.66% | 48.19M | |
-29.72% | 15.83B | |
-22.89% | 12.31B | |
-24.53% | 6.59B | |
+15.23% | 6.45B | |
-12.43% | 5.94B | |
+0.58% | 4.66B | |
+62.00% | 4.59B | |
-5.94% | 3.96B | |
-9.36% | 3.55B |
- Stock Market
- Equities
- ISPH Stock